Surgical treatment and prognostic factors in perihilar tumors
- 12 February 2024
- journal article
- abstracts
- Published by Media Sphere Publishing Group in Pirogov Russian Journal of Surgery
- No. 2,p. 14-23
Abstract
OBJECTIVE To study the results of surgical treatment in patients with perihilar tumors. MATERIAL AND METHODS We analyzed 98 patients with perihilar tumors who underwent surgery. RESULTS We prefer percutaneous transhepatic biliary drainage (n=58) for jaundice. Retrograde interventions were performed in 18 cases (20.5%), complications grade III—IV were more common (p=0.037) in the last group. Postoperative mortality was 12%. Complications developed in 81 patients (82.7%), grade ≥3 — in 39 (39.8%) cases. Portal vein resection (n=26) increased the incidence of complications grade ≥III (p=0.035) and portal vein thrombosis (p=0.0001). Chemotherapy after surgery was performed in 47 patients (48.0%), photodynamic therapy — in 7 (7.1%) patients. A 5-year overall survival was 28.1%, the median survival — 29 months. R2 resection and/or M1 stage (n=12) significantly worsened the prognosis and overall survival (16.5 vs. 31 months, p=0.0055). Lymph node (LN) lesion, microscopic status (R0 vs. R1) of resection margin, technique of decompression and isolated resection of extrahepatic bile ducts did not affect the prognosis, and we combined appropriate patients (n=72) for analysis. SI resection and excision of ≥6 lymph nodes were independent positive factors for disease-free survival (p=0.042 and p=0.007, respectively). Blood transfusion and high preoperative neutrophil-lymphocyte index (NLI ≥2.15) worsened overall (p=0.009 and p=0.002, respectively) and disease-free survival (p=0.002 and 0.007, respectively). The absence of adjuvant therapy worsened disease-free survival alone (p=0.024). CONCLUSION SI liver resection, adequate lymph node dissection and adjuvant therapy should be used for perihilar tumors. Isolated resection of extrahepatic bile ducts is permissible in some cases. Blood transfusion and NLI ≥2.15 are independent negative prognostic factors.Keywords
This publication has 23 references indexed in Scilit:
- Endoscopic versus percutaneous biliary drainage in patients with resectable perihilar cholangiocarcinoma: a multicentre, randomised controlled trialThe Lancet Gastroenterology & Hepatology, 2018
- Verification of the oncologic inferiority of percutaneous biliary drainage to endoscopic drainage: A propensity score matching analysis of resectable perihilar cholangiocarcinomaSurgery, 2017
- Postoperative Mortality after Liver Resection for Perihilar Cholangiocarcinoma: Development of a Risk Score and Importance of Biliary Drainage of the Future Liver RemnantJournal of the American College of Surgeons, 2016
- East or West, Who Grades Liver Failure After Liver Resection for Perihilar Cholangiocarcinoma Best?World Journal of Surgery, 2016
- Neoadjuvant treatment of biliary tract cancer: state-of-the-art and new perspectivesHepatic Oncology, 2015
- Percutaneous Preoperative Biliary Drainage for Resectable Perihilar Cholangiocarcinoma: No Association with Survival and No Increase in Seeding MetastasesAnnals of Surgical Oncology, 2015
- Oncological Superiority of Hilar En Bloc Resection for the Treatment of Hilar CholangiocarcinomaAnnals of Surgical Oncology, 2011
- A much needed but imperfect new staging systemNature Reviews Gastroenterology & Hepatology, 2011
- Adequate Lymph Node Assessment for Extrahepatic Bile Duct AdenocarcinomaAnnals of Surgery, 2010
- Long-Term Outcome of Extended Hemihepatectomy for Hilar Bile Duct Cancer With No Mortality and High Survival RateAnnals of Surgery, 2003